Tumor necrosis factor-α hyporesponsiveness of rat intestinal mononuclear cells and whole portal venous blood after hemorrhagic shock

Critical Care Medicine

Volumn 26, Issue 3, 1998, Pages 526-532

  Schröder, Jörg ^a   Kahlke, Volker ^a   Fändrich, Fred ^a   Zabel, Peter ^b   Kremer, Bernd ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b Department of Internal Medicine ^*  (Germany)

Author keywords

Compartmentalization; Cytokines; Hemorrhagic shock; Hyporesponsiveness; Interleukin 6; Macrophages; Mononuclear cells; Portal vein; Rat; Spleen; Tumor necrosis factor

Indexed keywords

ENDOTOXIN; INTERLEUKIN 6; RINGER LACTATE SOLUTION; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; CONTROLLED STUDY; CYTOKINE RELEASE; HEMORRHAGIC SHOCK; IMMUNOMODULATION; INTESTINE; MACROPHAGE; MALE; MONONUCLEAR CELL; NONHUMAN; PORTAL VEIN BLOOD; PRIORITY JOURNAL; RAT; REPERFUSION; SPLEEN;

ANIMALS; INTERLEUKIN-6; INTESTINE, SMALL; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MALE; PORTAL VEIN; RATS; RATS, WISTAR; SHOCK, HEMORRHAGIC; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031938605     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199803000-00027     Document Type: Article

References (37)

1. Chaudry IH, Ayala A, Ertel W, et al: Hemorrhage and resuscitation: Immunological aspects. Am J Physiol 1990; 259:663-678
2. Rush BF, Sori AJ, Murphy TF, et al: Endotoxemia and bacteremia during hemorrhagic shock. Ann Surg 1988; 207:549-554
3. Deitch EA, Bridges W, Baker J: Hemorrhagic shock-induced bacterial translocation is reduced by xanthine oxidase inhibition and inactivation. Surgery 1988; 104:191-198
4. Moore FA, Moore EE, Pogetti R, et al: Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. J Trauma 1991; 31:629-638
5. Maejima K, Deitch EA, Berg RD: Promotion of burn stress by the translocation of bacteria from the gastrointestinal tract of mice. Arch Surg 1984; 119:166-172
6. Deitch EA, Bridges RM: Effect of stress and trauma of bacterial translocation from the gut. J Surg Res 1987; 42:536-542
7. Ziegler TR, Smith RJ, O'Dwyer ST, et al: Increased intestinal permeability associated with infection in burn patients. Arch Surg 1988; 12:1313-1319
8. Deitch EA, Berg RD: Endotoxin but not malnutrition promotes bacterial translocation of the gut flora in burned mice. J Trauma 1987; 27:161-166
9. Jiang J, Bahrami S, Leitfried G, et al: Kinetics of endotoxin and tumor necrosis factor appearence in portal and systemic circulation after hemorrhagic shock in rats. Ann Surg 1995; 221:100-106
10. Deitch EA, Xu D, Franko L, et al: Evidence favouring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock 1994; 1:141-146
11. Yao Y-M, Bahrami S, Leichtfried G, et al: Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats. Ann Surg 1995; 221: 398-105
12. Golder JP, Doe WF: Isolation and preliminary characterization of human intestinal macrophages. Gastroenterology 1983; 84:795-802
13. Wacker HH, Heidebrecht HJ, Radzun HJ, et al: Sinus Lining cells: morphology, function and neoplasia. Verh Dtsch Ges Path 1992; 76:219-225
14. Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEH 164 subclone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986; 95:99-105
15. Aarden LA, de Groot ER, Schaap OL, et al: Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987; 17:1411-1416
16. Mester M, Tompkins RG, Gelfand JA, et al: Intestinal production of interleukin-1α during endotoxemia in mouse. J Surg Res 1993; 54:584-591
17. Meyer TA, Wang J, Tiao GM, et al: Sepsis and endotoxemia stimulate intestinal interleukin-6 production. Surgery 1995; 118:336-342
18. 2 by isolated enterocytes and gut macrophages: effect of lipopolysaccharide and thermal injury. J Burn Care Rehabil 1994; 15:470-477
19. Ayala A, Perrin MM, Meldrum DR, et al: Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine 1990; 2:170-174
20. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77:1627
21. Murch SH, Breagger CP, Walker-Smith JA, et al: Location of tumour necrosis factor-α by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993; 34:1705-1709
22. Gerlach H, Gerlach M, Clauss M: Relevance of tumour necrosis factor-alpha and interleukin-1-alpha in the pathogenesis of hypoxia-related organ failure. Eur J Anaesthesiol 1993; 10: 273-278
23. Ayala A, Kisala JM, Felt JA, et al: Does endotoxin tolerance prevent the release of inflammatory monokines (interleukin-1, interleukin-6, or tumor necrosis factor) during sepsis. Arch Surg 1992; 127:191-197
24. Ayala A, Deol ZK, Lehmann DL, et al: Does endotoxin play a major role in inducing the depression of macrophage function during polymicrobial sepsis? Arch Surg 1995; 130: 1178-1185
25. De Groote D, Zangerle PF, Gevaert Y, et al: Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. Comparison with isolated PBMC stimulation. Cytokine 1992; 4: 239-248
26. Holzheimer RG, Molloy R, Mendez MV, et al: Multiple system organ failure may be influenced by macrophage hypoactivation as well as hyperactivation-importance of the double challenge. Eur J Surg 1995; 161:795-803
27. Setter SC, Bennet T, Li MH, et al: Macrophage endotoxin tolerance. Arch Surg 1995; 129:1263-1270
28. Hauser CJ, Lagoo S, Lagoo A, et al: Tumor necrosis factor-α gene expression in human peritoneal macrophages is suppressed by extra-abdominal trauma. Arch Surg 1995; 130: 1186-1192
29. 2, nitric oxide, and speroxide by macrophages. J Trauma 1994; 37: 82-90
30. Rogy MA, Oldenburg HSA, Coyle S, et al: Correlation between Acute Physiology and Chronic Health Evaluation (APACHE) III score and irnmunological parameters in critically ill patients with sepsis. Br J Surg 1996; 83: 396-400
31. Ayala A, Perrin MM, Kisala JM, et al: Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophage to release inflammatory mediators (IL-1, IL-6, TNF). Circ Shock 1992; 36:191-199
32. Aderka D, De J, Vileck J: IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes. J Immunol 1989; 143:3517-3523
33. Barton BE, Jackson JV: Protective role of interleukin-6 in the lipopolysaccharide-galactosamine septic shock model. Infect Immun 1993; 61:1496-1499
34. Gennari R, Alexander JW: Anti-interleukin-6 antibody treatment improves survival during gut-derived sepsis in a time-dependant manner by enhancing host defense. Crit Care Med 1995; 23:1945-1953
35. Kim C, Schinkel C, Fuchs D, et al: Interleukin-13 effectively down-regulates the monocyte inflammatory potential during traumatic stress. Arch Surg 1995; 130:1330-1336
36. Nathens AB, Rotstein OD, Dackiw APB, et al: Intestinal epithelial cells down-regulate macrophage tumor necrosis factor-alpha secretion: A mechanism for immune homeostasis in the gut-associated lymphoid tissue. Surgery 1995; 118:343-351
37. Yao Y-M, Bahrami S, Redl H, et al: Monoclonal antibody to tumor necrosis factor-α attenuates hemodynamic dysfunction secondary to intestinal ischemia/reperfusion in rats. Crit Care Med 1996; 24:1547-1553